Johnson & Johnson Overview
Get informed when a big investor buys or sells
+ Follow-43.22
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for JNJ is -43.22. That is below the Healthcare sector average of 12.15. Investors often review this figure alongside Johnson & Johnson's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, JNJ currently prints -43.22 for PEG ratio, while the sector average sits near 12.15. That is roughly 455.6% below the sector mean. Large gaps often invite a closer look at Johnson & Johnson's growth, margins, and balance sheet.
A PEG ratio of -43.22 for Johnson & Johnson is not 'good' or 'bad' on its own. Compare it with the peer average (12.15) and with JNJ's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting JNJ's PEG ratio (-43.22), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Johnson & Johnson's PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
